急性卒中无症状出血事件与功能结局:DIRECT-MT随机临床试验的二次分析
本文为DIRECT-MT随机临床试验的二次分析,纳入490例接受血管内治疗(EVT)的急性缺血性卒中患者,比较无症状性出血性梗死(HI)和蛛网膜下腔出血(SAH)组(133例,27.1%)与无出血组(357例,72.9%)的90天功能结局。倾向性评分匹配后,无症状HI和SAH组90天mRS评分更差的OR为2.59(95%CI 1.45-4.63;P=0.001)。在mRS 0-1和0-2二分结局中,无症状HI和SAH在所有模型中均与更差恢复相关。作者认为,这些发现强调对取栓后无症状出血事件患者需密切监测和个体化管理策略。
要点
- EVT后无症状性出血性梗死和蛛网膜下腔出血发生率为27.1%(133/490),并非罕见。
- 倾向性评分匹配后,无症状HI和SAH组90天mRS更差的OR为2.59(95%CI 1.45-4.63;P=0.001)。
- 在mRS 0-1和0-2阈值下,无症状HI和SAH在所有模型中均与更差恢复相关。
- 作者认为,对取栓后无症状出血事件患者需密切监测和个体化管理策略。
适用人群与场景
- DIRECT-MT随机临床试验中接受血管内治疗(EVT)的急性缺血性卒中患者,纳入无症状性出血性梗死(HI)、蛛网膜下腔出血(SAH)或无出血者。
研究设计与关键结果
- 研究类型:DIRECT-MT随机临床试验的二次分析;多中心研究,2016年至2019年在中国三级医院开展,随访90天;本分析于2024年12月进行。
- 共纳入490例患者(中位[IQR]年龄70[60-76]岁;女性210例[42.9%]),无症状HI和SAH组133例(27.1%),无出血组357例(72.9%)。
- 主要结局:倾向性评分匹配后,无症状HI和SAH组相比无出血组90天mRS评分更差的OR为2.59(95%CI 1.45-4.63;P=0.001)。
- 次要结局:在mRS 0-1和0-2阈值下,无症状HI和SAH在所有模型中均与更差恢复相关。
证据类型、等级与局限
- 证据类型:随机临床试验的二次分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,这些发现强调对取栓后无症状出血事件患者需密切监测和个体化管理策略。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Asymptomatic hemorrhagic infarction (HI) and subarachnoid hemorrhage (SAH) after endovascular treatment (EVT) for acute ischemic stroke are commonly considered low risk, but their long-term impact on functional outcomes is unclear.
OBJECTIVE: To determine whether asymptomatic HI and SAH are associated with worse 90-day functional recovery in patients with acute ischemic stroke treated with EVT.
DESIGN, SETTING, AND PARTICIPANTS: This is a secondary analysis of the DIRECT-MT randomized clinical trial, which compared intravenous thrombolysis prior to EVT with EVT alone. The multicenter study was conducted at tertiary hospitals in China between 2016 and 2019 with 90-day follow-up. Trial patients with asymptomatic HI, SAH, or no hemorrhage were included in the present analysis, which was performed in December 2024.
EXPOSURE: Asymptomatic HI and SAH detected on follow-up imaging.
MAIN OUTCOMES AND MEASURES: The primary outcome was the score on the modified Rankin scale (mRS) assessed at 90 days. Secondary analyses categorized mRS scores into thresholds of 0 to 1, 0 to 2, and 0 to 3, representing excellent, good, and favorable recovery, respectively.
RESULTS: A total of 490 patients were included (median [IQR] age, 70 [60-76] years; 210 [42.9%] female), with 133 (27.1%) in the asymptomatic HI and SAH group and 357 (72.9%) in the no hemorrhage group. After propensity score matching, the odds ratio of having a worse mRS scores at 90 days in the asymptomatic HI and SAH group compared with the no hemorrhage group was 2.59 (95% CI, 1.45-4.63; P = .001). For binary outcomes, asymptomatic HI and SAH were consistently associated with worse recovery across mRS score thresholds of 0 to 1 and 0 to 2 in all models.
CONCLUSIONS AND RELEVANCE: In this secondary analysis of a randomized clinical trial, asymptomatic HI and SAH were associated with worse 90-day functional outcomes in patients with acute ischemic stroke treated with EVT. These findings emphasize the need for close monitoring and tailored management strategies in patients with asymptomatic hemorrhagic events following thrombectomy.
TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03469206.
参考来源
- Chen R, Hua W, Zhang Y, et al. Asymptomatic Hemorrhagic Events and Functional Outcomes in Acute Stroke: A Secondary Analysis of the DIRECT-MI Randomized Clinical Trial. JAMA Netw Open. 2025. PMID: 40152857. doi:10.1001/jamanetworkopen.2025.2411
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。